Rationale of the Week | Diabetes Burnout Despite Control?
For last week’s practice question, we quizzed participants on Diabetes Burnout Despite Control. 94% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question.
Question: Jada, a 29-year-old with type 1 diabetes, tells you she’s feeling burned out and emotionally drained, despite maintaining a time in range above 70% for the past several months. She says, “I’m doing everything right, but I’m exhausted and don’t feel like myself lately.” You review her CGM data and see no major red flags. She denies any recent illnesses or major changes in insulin needs. What is the most appropriate next step?
Answer Choices:
- Celebrate her strong glucose metrics and encourage her to stick with the same plan, reassuring her that she’s doing well.
- Recommend scheduling an appointment with her endocrinologist to reevaluate her insulin doses and technology settings.
- Acknowledge her experience and assess for emotional burnout, stressors, or imbalances in her lifestyle that could be contributing to her fatigue.
- Increase the frequency of data sharing and remote monitoring to help identify subtle trends and reduce her self-management burden.
Getting to the Best Answer
Answer 1 is incorrect. 1% chose this answer, “Celebrate her strong glucose metrics and encourage her to stick with the same plan, reassuring her that she’s doing well.” While it’s important to acknowledge the hard work it takes to stay in range, this answer misses the bigger picture. Jada is telling us she’s struggling emotionally — this is not the time to brush past her experience. High time in range does not always equal high quality of life. When someone shares they’re feeling burned out, it’s our cue to pause and dig deeper, not simply pat them on the back and move on.
Answer 2 is incorrect. 2% of you chose this answer, “Recommend scheduling an appointment with her endocrinologist to reevaluate her insulin doses and technology settings.” Jada isn’t expressing concerns about her insulin needs — she’s talking about emotional exhaustion. Jumping to insulin or tech adjustments may send the message that we’re not really listening. Yes, there’s always room to optimize settings, but that’s not the priority here. This response may unintentionally medicalize a problem that’s likely rooted in something else.
Answer 3 is correct. About 94% of respondents chose this, “Acknowledge her experience and assess for emotional burnout, stressors, or imbalances in her lifestyle that could be contributing to her fatigue.” YES — this is the best answer. Jada is doing a great job with her glucose, but she’s telling us she’s tired. Diabetes burnout is real, even when the data looks “perfect.” This is our opportunity to normalize her feelings, offer support, and explore what might be out of balance — whether it’s stress, sleep, relationships, or unrealistic expectations around self-management. Holistic care means seeing the person, not just the numbers.
Finally, Answer 4 is incorrect. 1% chose this answer, “Increase the frequency of data sharing and remote monitoring to help identify subtle trends and reduce her self-management burden.” While that might sound helpful, more data is not necessarily the answer here. In fact, increasing monitoring could add to Jada’s mental load — and she’s already telling us she’s exhausted. If anything, now might be a time to consider reducing the burden, simplifying routines, or talking about boundaries with diabetes tech.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Want to learn more about this question?
Join us live on July 24th for our
Level 5: Beyond Blood Glucose: Empowering Health Through a Holistic Lens
Join us live on July 24th, 2025, at 11:30 am PST to watch our brand new webinar, Beyond Blood Glucose: Empowering Health Through a Holistic Lens by Nick Kundrat, BS, CEP, CDCES, LMT
Despite the rise of cutting-edge diabetes technologies and therapeutics, many people with diabetes still struggle with fatigue, blood glucose swings, and burnout. Why? Because we’re often so focused on managing diabetes itself that we often forget to take care of the human being who lives with it.
Join Nick Kundrat, BS, CEP, CDCES, LMT and Integrative Health Practitioner, for an engaging webinar where he simplifies the often-misunderstood world of holistic health. You’ll learn practical, accessible strategies to begin thinking more holistically and discover simple, effective tools that enhance conventional care and empower people with diabetes to thrive—physically, emotionally, and spiritually.
Drawing from over two decades of lived experience with type 1 diabetes and years of supporting clients in both clinical and holistic settings, Nick offers a unique perspective on diabetes care focused on the whole person. Through reconnecting with the foundational elements of health, which are often overlooked in conventional diabetes care, Nick aims to equip you with actionable strategies to help people with diabetes restore their energy, support their bodies, and thrive beyond diabetes.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Rationale of the Week | Current Hormone Therapy Guidance in T2D
For last week’s practice question, our special guest expert Jill Schramm, DNP, FNP-C, BC-ADM, CDCES quizzed us on Current Hormone Therapy Guidance for people with T2D. 57% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: Which statement accurately reflects current guidelines on hormone therapy (HT) in postmenopausal women with type 2 diabetes?
Answer Choices:
- Oral estrogen is preferred over transdermal forms due to better metabolic outcomes.
- Progesterone levels increase post-menopause, exacerbating insulin resistance.
- Transdermal estrogen may improve insulin sensitivity and carries a lower thrombotic risk compared to oral
estrogen. - Testosterone levels rise during menopause, leading to increased central adiposity.
Getting to the Best Answer
Answer 1 is incorrect. 10% chose this answer, “Oral estrogen is preferred over transdermal forms due to better metabolic outcomes.” Oral estrogen undergoes first-pass hepatic metabolism, which can negatively influence clotting factors. Transdermal estrogen bypasses the liver and is generally favored in women with cardiometabolic risk, such as those with type 2 diabetes.
Reference: The Menopause Society, 2022; American Diabetes Association (ADA) Standards of Care in Diabetes; 2025.
Answer 2 is incorrect. 16% of you chose this answer, “Progesterone levels increase post-menopause, exacerbating insulin resistance.” Progesterone levels actually decrease after menopause due to ovarian senescence. There is no physiological increase in progesterone levels that would worsen insulin resistance during the postmenopausal years.
Reference: The Menopause Society, 2022.
Answer 3 is correct. About 57% of respondents chose this, “Transdermal estrogen may improve insulin sensitivity and carries a lower thrombotic risk compared to oral estrogen.” GREAT JOB. This is the best answer and aligns with current guidelines. Transdermal estrogen has been shown to improve insulin sensitivity and does not increase hepatic production of clotting factors the way oral estrogen does. As a result, it is associated with a lower risk of venous thromboembolism, making it a safer option for postmenopausal women with metabolic concerns such as type 2 diabetes.
Reference: The Menopause Society (formerly NAMS), 2022 Position Statement
Finally, Answer 4 is incorrect. 14% chose this answer, “Testosterone levels rise during menopause, leading to increased central adiposity.“Testosterone levels generally decline with age and menopause, although the ratio of testosterone to estrogen may shift due to declining estrogen. While visceral adiposity does tend to increase in menopause, it is more directly related to estrogen deficiency rather than a surge in testosterone.
Reference: The Menopause Society, 2022.
Thanks to Jill Schramm, DNP, FNP-C, BC-ADM, CDCES for her providing us with these terrific insights into menopause. Join her presentation on August 27th to learn more! See info below. Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Want to learn more about this question?
Join us live on August 27th for our
Level 5: Hot Flashes & Hyperglycemia: What Clinicians Need to Know
Join us live on August 27th, 2025, at 11:30 am PST to watch our brand new webinar, Hot Flashes & Hyperglycemia: What Clinicians Need to Know by Dr. Jill Schramm, DNP, FNP-C, BC-ADM, CDCES
The intersection of menopause and diabetes is often underrecognized in clinical care, yet people with diabetes in menopausal transition face unique metabolic, hormonal, and lifestyle changes that can significantly impact glycemic control. This session explores the physiological shifts of menopause, the implications for insulin resistance, and evidence-based strategies for individualized care. Attendees will leave with practical guidance on hormone therapy, lifestyle management, and education tools to improve outcomes for people with diabetes navigating both diabetes and the menopausal transition.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Rationale of the Week | T1D and Artificial Sweeteners: Safe Limits
For last week’s practice question, we quizzed participants on T1D and Artificial Sweeteners: Safe Limits. 95% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: Sam is a 28-year-old with type 1 diabetes who reports drinking six diet sodas per day, believing they help manage blood sugar. Sam asks if this is safe or if they should reduce consumption. What would be an appropriate response based on the 2025 ADA Standards of Care?
Answer Choices:
- You should avoid diet soda and all non-nutritive sweeteners because they’re linked to cancer and heart disease.
- Diet sodas are completely safe, so there’s no reason to change your intake.
- While non-nutritive sweeteners are FDA-approved, let’s discuss your current intake, concerns, and whether unsweetened beverages may be a better option.
- Switch to natural sugars like honey or agave syrup since they are healthier than artificial sweeteners.
Getting to the Best Answer
Answer 1 is incorrect. 1% chose this answer, “You should avoid diet soda and all non-nutritive sweeteners because they’re linked to cancer and heart disease.” While concerns about non-nutritive sweeteners (NNS) exist, especially aspartame and erythritol, the ADA and FDA consider approved sweeteners safe and within acceptable daily intake levels. Blanket avoidance is not person-centered nor based on current evidence.
Answer 2 is incorrect. 1% of you chose this answer, “Diet sodas are completely safe, so there’s no reason to change your intake.” Although NNS are considered safe by the FDA, the ADA recommends moderation. It supports reducing the total intake of sweetened beverages and those with NNS, encouraging water and unsweetened options where possible.
Answer 3 is correct. About 95% of respondents chose this – GREAT JOB! “While non-nutritive sweeteners are FDA-approved, let’s discuss your current intake, concerns, and whether unsweetened beverages may be a better option.” The 2025 ADA Standards of Care support a person-centered approach and recognize that FDA-approved non-nutritive sweeteners (NNS) are safe when used in moderation. This answer allows for a discussion tailored to Sam’s health goals, type of sweetener consumed and specific concerns. While water is the preferred beverage, using NNS to replace sugar-sweetened drinks may be an option to reduce overall calorie and carbohydrate intake.
Finally, Answer 4 is incorrect. 1% chose this answer, “Switch to natural sugars like honey or agave syrup since they are healthier than artificial sweeteners.” Natural sugars like honey and agave, although considered natural, are a form of added sugar that can negatively affect blood glucose. There is no specific guidance for the amount of added sugar within the diet, but the ADA Standards of Care recommends minimizing all forms of added sugar while also considering an individual’s nutrition plan.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Want to learn more about holistic care from our guest expert, Nick Kundrat?
Join us live on July 24th for Beyond Blood Glucose: Empowering Health Through a Holistic Lens
Join us live on July 24th, 2025, at 11:30 am PST to watch our brand new webinar, Beyond Blood Glucose: Empowering Health Through a Holistic Lens by Nick Kundrat, BS, CEP, CDCES, LMT
Despite the rise of cutting-edge diabetes technologies and therapeutics, many people with diabetes still struggle with fatigue, blood glucose swings, and burnout. Why? Because we’re often so focused on managing diabetes itself that we often forget to take care of the human being who lives with it.
Join Nick Kundrat, BS, CEP, CDCES, LMT and Integrative Health Practitioner, for an engaging webinar where he simplifies the often-misunderstood world of holistic health. You’ll learn practical, accessible strategies to begin thinking more holistically and discover simple, effective tools that enhance conventional care and empower people with diabetes to thrive—physically, emotionally, and spiritually.
Drawing from over two decades of lived experience with type 1 diabetes and years of supporting clients in both clinical and holistic settings, Nick offers a unique perspective on diabetes care focused on the whole person. Through reconnecting with the foundational elements of health, which are often overlooked in conventional diabetes care, Nick aims to equip you with actionable strategies to help people with diabetes restore their energy, support their bodies, and thrive beyond diabetes.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Rationale of the Week | CGM Timing Post-T1D Diagnosis: ADA 2025
For last week’s practice question, we quizzed participants on CGM Timing Post-T1D Diagnosis: ADA 2025. 95% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: JT, a 17-year-old recently hospitalized with a new diagnosis of type 1 diabetes, is using
Multiple Daily Injections (MDI) therapy. JT uses fingerstick blood glucose monitoring but
wants to move to a CGM. JT’s mother wants to know how long fingerstick monitoring must
be used before a CGM can be started. According to the ADA 2025 Standards of Care, when
can a CGM be initiated after a type 1 diabetes diagnosis?
Answer Choices:
- CGM is to be initiated when an individual with type 1 diabetes does not meet glycemic
targets. - CGM is to be initiated only when an individual with type 1 diabetes is started on
continuous subcutaneous insulin infusion (CSII) therapy. - CGM can be initiated when an individual with type 1 diabetes is ready and able, and the individual or caregiver has been educated on its use, even at diagnosis.
- CGM is to be initiated when an individual with type 1 diabetes is over the age of 18.
Getting to the Best Answer
Answer 1 is incorrect. 1% chose this answer, “CGM is to be initiated when an individual with type 1 diabetes does not meet glycemic targets”. Since CGM is not used only for those with elevated glucose levels, this is not the best answer.
Answer 2 is incorrect. 1% of you chose this answer, “CGM is to be initiated only when an individual with type 1 diabetes is started on continuous subcutaneous insulin infusion (CSII) therapy”. Actually, CGM technology can be used with or without CSII (either standard pump or AID systems).
Answer 3 is correct. About 95% of respondents chose this, “CGM can be initiated when an individual with type 1 diabetes is ready and able, and the individual or caregiver has been educated on its use, even at diagnosis.” GREAT JOB! According to the American Diabetes Association 2025 Standards of Care, CGM technology can be initiated in any person living with diabetes on insulin therapy as early as diagnosis. The diabetes education specialist will use an individualized approach in choosing the most appropriate CGM technology and educating the individual and caregiver on how to use it. “
Finally, Answer 4 is incorrect. 1% chose this answer, “CGM is to be initiated when an individual with type 1 diabetes is over the age of 18.” According to the ADA 2025 Standards of Care, CGM technology should be offered to any adult or youth using insulin therapy. Some CGM devices are approved for use in the pediatric population (refer to each specific CGM for approval for use in children).
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Join us for this upcoming ADA Standards Webinar!
Level 2: From Tots to Teens with Diabetes
Join us live today June 12, 2025, at 11:30 am PST
This course is part of Level 2 – Standards of Care.
Course Overview:
This course covers updated care goals and guidelines for children with type 1 or type 2 diabetes. Topics include clinical presentation, developmentally appropriate care, complication prevention, and family support.
Learn anytime, anywhere with 1-year access. Each course includes a video, podcast, practice test, and resources.
Objectives:
Identify care goals for kids with Type 1 and Type 2 diabetes
Outline strategies to prevent complications
Emphasize positive psychosocial support
Learning Outcome:
Gain a thorough understanding of individualized care and standards for pediatric diabetes management.
Buy individually for $29 or get the full Level 2 Bundle and save 45% (discount applied). Don’t worry if you cannot attend, the course includes access to the recording for one year!
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Rationale of the Week | DKA Prevention After T1D Diagnosis
For last week’s practice question, we quizzed participants on DKA Prevention After T1D Diagnosis. 52% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: A 10-year-old child with newly diagnosed type 1 diabetes is being discharged from the hospital. Which of the following components is most critical to include in the initial outpatient diabetes management plan to reduce the risk of diabetic ketoacidosis (DKA) and hospital readmission?
Answer Choices:
- Initiate basal insulin therapy and MNT instruction, with follow-up in two weeks.
- Provide basic carbohydrate counting and bolus insulin instruction with a follow-up appointment within 30 days.
- Establish follow up with a specialist within a week and provide actions to take in case of glucose emergencies.
- Prescribe continuous glucose monitoring (CGM) and glucagon rescue medication and ask family to schedule a follow-up appointment after the sensor is delivered and set up.
Getting to the Best Answer
Answer 1 is incorrect. 21% chose this answer, “Initiate basal insulin therapy and MNT instruction, with follow-up in two weeks.” Basal insulin alone is insufficient; children require both basal and bolus insulin to mimic physiologic insulin needs and prevent DKA.
Answer 2 is incorrect. 13% of you chose this answer, “Provide basic carbohydrate counting and bolus insulin instruction with a follow-up appointment within 30 days.” Delayed follow-up increases the risk of complications. Carbohydrate counting and bolus insulin are important, but must be paired with timely, ongoing support.
Answer 3 is correct. About 52% of respondents chose this, “Establish follow up with a specialist within a week and provide actions to take in case of glucose emergencies.” Early involvement of a diabetes specialist and problem solving in case of glucose crises, significantly reduce the risk of DKA and readmission. Frequent follow-up in the first week is associated with better outcomes.
Finally, Answer 4 is incorrect. 13% chose this answer, “Prescribe continuous glucose monitoring (CGM) and glucagon rescue medication and ask family to schedule a follow-up appointment after the sensor is delivered and set up.” While CGM is valuable, delaying education and clinical engagement is risky; immediate education and care planning are essential.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Join us live on June 11th @ 11:30am PST!
Level 5 | Mindful Eating for Successful Diabetes Management
Join us live on June 11, 2025, at 11:30 am PST to watch our brand new webinar, Mindful Eating for Successful Diabetes Management by Evgeniya Evans, MS, RDN, CDCES
This engaging and practical webinar, developed by Evgeniya Evans, MS, RDN, CDCES, a positive psychology practitioner, is tailored explicitly for healthcare professionals including dietitians, diabetes care specialists, and providers.
Using evidence-based strategies, participants will gain a deeper understanding of the benefits of incorporating mindfulness into the eating experience, including enhanced glycemic management, improved emotional well-being, and healthier eating behaviors. The webinar includes an overview of mindfulness and mindful eating strategies, such as engaging all five senses, recognizing hunger cues, addressing cravings, and using practical tools to create supportive eating environments.
Participants will also learn how to adapt these approaches to diverse populations and the unique needs of individuals. Join us to deepen your expertise, participate in insightful discussions, and empower individuals to cultivate sustainable, positive relationships with food while achieving long-term health goals.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Rationale of the Week | ADA 2025: Which MNT Statement Is False?
For last week’s practice question, we quizzed participants on ADA 2025: Which MNT Statement Is False? 50% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: According to the 2025 ADA Standards of Care, which of the following statements about medical nutrition therapy (MNT) for adults with type 2 diabetes is NOT TRUE?
Answer Choices:
- A low-carbohydrate diet eating pattern of <26% of calories from carbohydrates can lead to a reduction in A1c.
- Nutrition therapy provided by a registered dietitian nutritionist (RDN) can result in A1C reductions of up to 0.5%.
- Individualized nutrition therapy should begin at diagnosis.
- A Mediterranean eating pattern can reduce the risk of major cardiovascular disease events.
Getting to the Best Answer
Answer 1 is incorrect. 29% chose this answer, “A low-carbohydrate diet eating pattern of <26% of calories from carbohydrates can lead to a reduction in A1c.” Low-carbohydrate eating patterns (defined as <26% of calories from carbohydrates) have been shown to lower A1C in adults with type 2 diabetes and are supported by the 2025 ADA Standards of Care as one of several individualized eating patterns.
Answer 2 is correct. 50% of you chose this answer, “Nutrition therapy provided by a registered dietitian nutritionist (RDN) can result in A1C reductions of up to 0.5%.” The 2025 ADA Standards of Care state that medical nutrition therapy (MNT) provided by an RDN can lead to A1C reductions of 0.3% to 2%, especially in individuals with type 2 diabetes. The answer is not true because a 0.5% reduction underestimates the potential benefit.
Answer 3 is incorrect. About 11% of respondents chose this, “Individualized nutrition therapy should begin at diagnosis.” The ADA recommends that individualized MNT should be initiated at the time of diagnosis. Additional times for referral include annually or when not meeting treatment goals, when complications occur or when transitions in life occur.
Finally, Answer 4 is incorrect. 8% chose this answer, “A Mediterranean eating pattern can reduce the risk of major cardiovascular disease events.” The Mediterranean eating pattern has been associated with improved glycemic control and a reduced risk of cardiovascular events, making it an eating pattern to consider for people with type 2 diabetes.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Join us June 5th @ 11:30am PST for this Upcoming Level 5 Course!
Weight – Inclusive Diabetes Care: Turning Compassion into Practical Tools
Join us live on June 5, 2025, at 11:30 am PST to watch our brand new webinar, Weight-Inclusive Diabetes Care: Turning Compassion into Practical Tools by Jessica Jones, MS, RDN, CDCES
This session provides healthcare providers with actionable strategies to integrate weight-inclusive care into diabetes management practices, focusing on improving outcomes through respect for body diversity and individual autonomy. Weight stigma is a well-documented barrier to effective care, contributing to poorer glycemic control, disordered eating, and care avoidance. By shifting from a weight-focused approach to one aligned with Health at Every Size (HAES®), providers can foster trust, enhance participant engagement, and support sustainable health behaviors.
Jessica Jones, MS, RD, CDCES, will share evidence-based insights on mitigating weight stigma and applying HAES-aligned strategies in practice. Participants will learn how to build rapport, set realistic nutrition goals, and implement interventions that prioritize blood sugar management, joyful movement, and intuitive eating. This session equips providers with tools to deliver compassionate, person-centered care, improving both clinical outcomes and the provider-participant relationship.
Course topics:
- Foundations of weight-inclusive diabetes care: overview and evidence
- Shifting perspectives: building trust and redefining success
- Practical tools for sustainable blood sugar management
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Rationale of the Week | How much do you know about Coach Bev?
For last week’s practice question, we quizzed participants on How Well Do You Know Coach Bev? 33% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: Which early job taught Coach Beverly the value of loving your work and providing excellent service?
Answer Choices:
- Working as a monitor technician at a community hospital.
- Volunteering at a convalescent hospital after school.
- Showing up at Ying’s Kitchen Chinese Food Restaurant.
- Babysitting a family of six kids during the summer.
Getting to the Best Answer
Answer 1 is incorrect. 22% chose this answer, “Working as a monitor technician at a community hospital.” Beverly worked as a monitor tech and nurses aide at a community hospital while attending nursing school. These experiences taught her about navigating medical terminology and hospital systems.
Answer 2 is incorrect. 25% of you chose this answer, “Volunteering at a convalescent hospital after school.” Coach Bev did lead Bingo games and play guitar at a convalesent home after school. She loved connecting with older adults and hearing their stories.
Answer 3 is correct. About 33% of respondents chose this, “Showing up at Ying’s Kitchen Chinese Food Restaurant.” This is the best answer. Her 8 years at Ying’s Kitchen taught her about hard work, attention to detail, and loving what you do.
Finally, Answer 4 is incorrect. 18% chose this answer, “Babysitting a family of six kids during the summer.” Watching 6 kids over the summer helped her recognize that being a parent has lots of perks, but she wasn’t ready.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
Want to learn more about this question?
Read our Blog about Coach Bev’s time at Ying’s Kitchen!
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
Rationale of the Week | Decoding AGP Report – Test Your Knowledge!
For last week’s practice question, we quizzed participants on Decoding AGP Report-Test Your Knowledge. 49% of respondents chose the best answer. We want to clarify and share this important information, so you can pass it on to people living with diabetes and your colleagues, plus prepare for exam success!
Before we start though, if you don’t want any spoilers and haven’t tried the question yet, you can answer it below: Answer Question
Question: AJ asks you why their blood glucose levels are “all over the place”. When you look at the AGP, you notice the coefficient of variation is 26%. What is the best response?
Answer Choices:
- Even though your coefficient of variation is above target, we can work to bring that down.
- It seems like you are making a big effort keep your glucose in target range.
- Given your glucose fluctuations, we may need to intensify your medication regimen.
- With some small changes in lifestyle activities, I am sure you can make improvements.
Getting to the Best Answer
Answer 1 is incorrect. 19% chose this answer, “Even though your coefficient of variation is above target, we can work to bring that down.” According to ADA Standards, the goal for glucose variability (or coefficient of variation) is less than 36%. AJ has a coefficient of variation of 26%, which is significantly below the target. This is a wonderful opportunity to recognize AJ’s self-management efforts.
Answer 2 is correct. 49% of you chose this answer, “It seems like you are making a big effort keep your glucose in target range.” YES, this is the BEST Answer. AJ has a coefficient of variation of 26%. That is 10% below the target of 36%. This is a wonderful opportunity to recognize AJ’s self-management efforts.
Answer 3 is incorrect. About 13% of respondents chose this, “Given your glucose fluctuations, we may need to intensify your medication regimen.” According to ADA Standards, the goal for glucose variability (or coefficient of variation) is less than 36%. AJ has a coefficient of variation of 26%, which is significantly below the target. This is a wonderful opportunity to recognize AJ’s self-management efforts.
Finally, Answer 4 is incorrect. 17% chose this answer, “With some small changes in lifestyle activities, I am sure you can make improvements.” According to ADA Standards, the goal for glucose variability (or coefficient of variation) is less than 36%. AJ has a coefficient of variation of 26%, which is significantly below the target. This is a wonderful opportunity to recognize AJ’s self-management efforts.
We hope you appreciate this week’s rationale! Thank you so much for taking the time to answer our Question of the Week and participate in this fun learning activity!
There’s Still Time! 🕒
Join us today for Part 2 of Tech Data Toolkit!
*Don’t worry if you missed the first session. All of our webinars are recorded and ready for OnDemand Viewing!
Dr. Diana Isaacs speaks live today @ 11:30am PST today!
Dr. Isaacs has a special knack for breaking down the essential elements of the Ambulatory Glucose Profile (AGP) report to provide participants with a clear road map for data interpretation. She includes many sample practice cases utilizing CGM data for various types of people with diabetes including type 2 and people with type 1 not on pumps.
Topics include:
- Review CGM key metrics and individualize time in-range goals
- Learn how to recognize patterns with the AGP report efficiently
- Utilize the AGP report as a discussion guide when meeting with a person with diabetes
- Fresh approach to lifestyle and medication adjustments based on CGM data.
All hours earned count toward your CDCES Accreditation Information
Sign up for Diabetes Blog Bytes – we post weekly Blog Bytes that are informative and FREE! Every week we post one exam practice Question of the Week and Rationale of the Week. Sign up below!
The use of DES products does not guarantee the successful passage of the certification exam. CBDCE and ADCES do not endorse any preparatory or review materials for the CDCES or BC-ADM exams, except for those published by CBDCE & ADCES.
![](/wp-content/uploads/2023/01/insta-png-v5.png")
